Testicular steroidogenesis in the fetal rat is activated before the onset of pituitary gonadotropin secretion. We studied here whether the pituitary adenylate cyclase-activating polypeptide (PACAP) could regulate this early Leydig cell activity. Effects of the two PACAP forms, 27 and 38, were studied on cAMP and testosterone production of dispersed Leydig cells of embryonic Day (E) 18.5. Furthermore, PACAP and PACAP type I receptor mRNA expression were measured by reverse transcription-polymerase chain reaction (RT-PCR), and testicular PACAP concentations by RIA. The two peptides were highly potent stimulators of fetal testes. Doses as low as 10 Ϫ18 mol/L of PACAP-27 and 10
INTRODUCTION
Pituitary adenylate cyclase-activating polypeptide (PA-CAP) has been isolated from ovine hypothalamic tissues on the basis of its ability to stimulate adenylate cyclase in cultured rat anterior pituitary cells [1] . Pituitary adenylate cyclase-activating polypeptide exists in two forms: a longer form of 38 amino acids (PACAP-38) and a shorter one (PACAP-27) containing the 27 N-terminal amino acids of PACAP-38. Pituitary adenylate cyclase-activating polypeptide belongs to the secretin/glucagon/vasoactive intestinal peptide (VIP) family of peptides [2] .
Pituitary adenylate cyclase-activating polypeptide functions as a neurotransmitter, neuromodulator, and neurotrophic factor [2] [3] [4] in the central nervous system, and it is also widely distributed in endocrine organs [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Pitui- tary adenylate cyclase-activating polypeptide and its type I receptor were found in abundance in the adrenal medulla [4] , where it may act as a potent noncholinergic secretagogue for catecholamines. Similarly, PACAP appears to play a regulatory role in insulin secretion [5] . Pituitary adenylate cyclase-activating polypeptide is considered a key player in the regulation of reproduction due to its effects at all levels of the hypothalamic-pituitary-gonadal axis. Pituitary adenylate cyclase-activating polypeptide acts in the hypothalamus to modulate the release of hormones such as LH and prolactin, probably by regulating the release of other hypophysiotropic factors such as GnRH, growth hormone-releasing hormone, and dopamine [6] [7] [8] . Additionally, PACAP has direct effects on pituitary gonadotroph cells by stimulating their LH release, as has been demonstrated in male rats in vivo [9] . Likewise, it stimulates the release of LH, FSH, and the common ␣-subunit in monolayer cultures of rat pituitary cells [10, 11] . Pituitary adenylate cyclase-activating polypeptide has been detected in the male and female urogenital system [12] [13] [14] [15] . In the testis it might act as a paracrine or autocrine regulator of Sertoli and germ cells with a specific function during early spermiogenesis [13, 14] , whereas in the female it may regulate the ovarian steroidogenic activity [15] .
Both forms of PACAP bind to the same receptor, which exists as two major subtypes [8] . The type I PACAP receptors exhibit 100-1000 higher affinity for PACAP-27 and PACAP-38 than for VIP. The second type of receptor has the same affinity for PACAP-38, PACAP-27, and VIP. The latter receptor type can be subdivided into the classic VIPbinding site (also termed VIP1 receptor) and the helodermin-preferring sites (also known as VIP2 receptor) [8] .
In fetal life, PACAP and PACAP receptors are expressed in the fetal brain as early as embryonic Day (E) 14.5 [16] . Pituitary adenylate cyclase-activating polypeptide may act as a trophic factor in the brain, involved in control of multiplication, differentiation, and/or migration of cells, based on its potent effect on cell proliferation, neurite outgrowth, and protein synthesis [17] [18] [19] . However, no reports on possible endocrine effects of PACAP during fetal life have been published.
Here, we have elaborated our preliminary finding that PACAP has a specific stimulatory effect on fetal testicular steroidogenesis [20] . To this end, we studied the dose-response effects of PACAP-27 and PACAP-38 on cAMP and testosterone production of dispersed fetal Leydig cells of E18.5 and followed this effect with advancing age of animals. We also explored expression of the PACAP and PA-CAP type I receptor genes in fetal testes. Finally, the testicular concentrations of both forms of PACAP were measured at different fetal ages.
MATERIALS AND METHODS

Animals and Experimental Design
Adult (2-to 3-mo-old) rats of the Sprague-Dawley strain (produced in our own vivarium) were housed under con-trolled photoperiod (14L:10D) and fed with commercial diet and water ad libitum. Females were caged with males overnight and checked the following morning for sperm in vaginal smear. The day after the night of mating was designated Day 0.5 of gestation, the day of birth was designated postnatal Day 1. Pups were housed with mothers in maternity cages until killed at 7, 13, 15, 16, or 20 days of age. Mothers were killed by decapitation under light CO 2 anesthesia at daily intervals between E15.5 and E21.5. The fetuses were excised, pinned on a silicon rubber mat, the abdominal wall was opened, and the testes were removed, weighed, snap-frozen in liquid nitrogen, and stored at Ϫ70ЊC until used for analysis of PACAP content or mRNA. Alternatively, the testes were excised under sterile conditions and placed into ice-cold medium ( 
Cultures of Dispersed Leydig Cells
The medium containing the fetal testes was changed into 15 ml of culture medium containing 0.4% collagenase type II (Sigma), and DNAse I (10 5 Kunitz units/L, Sigma), and the testes were incubated for 30 min at 37ЊC in a shaking water bath. Thereafter, the testes were dispersed mechanically by aspirating the tissue suspension through a pipette at 5-min intervals, continuing incubation until the tissue was completely disintegrated. The cells were then centrifuged at 200 ϫ g for 5 min at 4ЊC, and the supernatant was discarded. The cells were finally washed twice with 50 ml of medium, resuspended in fresh medium, divided equally into a 24-well culture plate (Nunc, Roskilde, Denmark), and allowed to recover and stabilize for 24 h at 37ЊC in an atmosphere of 5% CO 2 in air. The purity of the Leydig cells was assessed by cytochemical 3␤-hydroxysteroid dehydrogenase (3␤-HSD) reaction, and 30-40% of 3␤-HSD positive cells were found in the fetal testicular cell suspensions [20] . Thereafter, the medium was removed, and 1.0 ml of fresh medium containing 0.2 mmol/L 1-methyl-3-isobutylxanthine (MIX, Aldrich Chemie, Steinheim, Germany) and 10 Ϫ19 to 10 Ϫ6 mol/L of PACAP-27 or PACAP-38 (Peninsula Labs., Inc., Belmont, CA), or 30 g/L of highly purified hCG (CR-121, 11 500 IU/mg, NIH, Bethesda, MD) were added and the cells incubated for 4 h. Thereafter, the medium was collected, (diluted 1:1 with 2 mmol/L theophylline [Sigma] in the case of cAMP measurement), heated at 100ЊC for 5 min, and stored at Ϫ20ЊC until analyzed (see below). The same steps were followed in dispersion and culture of Leydig cells of neonatal and immature rats after decapsulation of testes. All the experiments were run in triplicate or quadruplicate and repeated at least two times.
Culture of MSC-1 Cells
The MSC-1 cells are an immortalized Sertoli cell line derived from testicular tumor of a transgenic mouse carrying a fusion gene composed of the human anti-Müllerian hormone transcripitional regulatory sequences linked to the coding sequence of simian virus 40 T-antigen [21] . One day before stimulation, the cells were plated into 24-well culture dishes (Greiner Labortechnik, Frickenhausen, Germany) at a density of 10 5 cells/well. The next day the medium was changed, and the cells were incubated in 0.5 ml culture medium (see above) in the presence and absence of 10 Ϫ7 -10 Ϫ13 mol/L PACAP-27 or PACAP-38, with a final concentration of 0.2 mmol/L of MIX. The cells were incubated for 4 h at 37ЊC in an atmosphere of 5% CO 2 in air, then the medium was collected, diluted 1:1 with 2 mmol/L theophylline, heated at 100ЊC for 5 min, and stored at Ϫ20ЊC until required for cAMP measurements (see below).
Isolation, Purification, and Culture of Adult Leydig Cells
For isolation and purification of adult Leydig cells, we used a previously described method [22] . In brief, the testes were decapsulated carefully and incubated in 10 ml of culture medium for 10 min at 34ЊC in an atmosphere of 5% CO 2 in air in the presence of 0.3 mg/L collagenase type II (Sigma). After incubation, the tube (50 ml Falcon) was filled with medium and allowed to stand for 5 min at room temperature. The supernatant containing the dissociated interstitial cells was filtered through nylon gauze and centrifuged at 120 ϫ g for 10 min. The resulting cell pellet was washed twice with medium and subjected to purification in a 50-ml continuous Percoll (Pharmacia, Uppsala, Sweden) gradient (density range 1.01-1.12 kg/L). After centrifugation (800 ϫ g for 20 min at room temperature), the cell layer containing the purest Leydig cells (density ϳ1.05 kg/ L) was collected, washed with medium, and incubated on 24-well plates (10 5 cells in 1.0 ml medium/well). The purity of the Leydig cells was assessed by the cytochemical 3␤-HSD reaction [23] after Percoll fractionation, and 75-85% of 3␤-HSD-positive cells were found. The purified Leydig cells were allowed to attach for 24 h in an atmosphere of 5% CO 2 in air at 37ЊC, after which the medium was changed and the cells were stimulated as described above.
Extraction of RNA
Total RNA was isolated from the adult and fetal tissues by the single step acid guanidinium thiocyanate-phenolchloroform extraction method as described before [24] .
Reverse Transcription-Polymerase Chain Reaction
Reverse transcription-polymerase chain reaction (RT-PCR) was used in order to screen the expression of PACAP and type I PACAP receptor mRNAs. For this purpose the following oligonucleotide primers were used: 1) PACAP mRNA: sense primer 5Ј-GTGACGCCTACGCCCTTTAC-TACC-3Ј (PACAP S ) and antisense primer 5Ј-GCTA-TTCGGCGTCCTTTGTTTTT-3Ј (PACAP AS ), corresponding to nucleotides 398-422 and 691-713 of the rat PACAP cDNA sequence, respectively [25] ; 2) PACAP type I receptor mRNA: sense primer 5Ј-TTAACTTTGTCTTTT-CATCGGC-3Ј (PACAP type I receptor S ) and antisense primer 5Ј-TCCCTCTTGCTGACGTTCTC-3Ј (PACAP type I receptor AS ) corresponding to nucleotides 952-976 and 1118-1133 of the rat PACAP type I receptor cDNA sequence, respectively [26] . The primers used for amplification of PACAP mRNA were designed to span over intron 4 of the PACAP gene, assuming that the human and rat PACAP genes are structurally similar [27] , thus allowing the exclusion of potential contamination with genomic DNA. For PACAP type I receptors, the primers were selected to amplify an area where alternative splicing takes place, giving rise to different mRNA transcripts according to a previous report [28] . The RT and PCR reactions were performed sequentially in the same tube [29] . Fifty microliters of the RT-PCR mixture contained 1 nmol/L of each oligo primer, 200 mol/L dNTPs, 1.5 mmol/L MgCl 2 , 20 U RNasin (Promega, Madison, WI), 12.5 U avian myeloblastosis virus reverse transcriptase, and 2.5 U Dynazyme-DNA polymerase (Finnzymes Oy, Espoo, Finland). The reaction was started at 50ЊC for 10 min (RT), followed by a period of 3 min at 97ЊC, and then run for 40 PCR cycles (96ЊC for 1.5 min, 57ЊC for 1.5 min, 72ЊC for 3 min), and final extension for 10 min at 72ЊC. For all reactions, liquid controls were run in parallel with RNA samples. These control samples yielded negative reactions.
Southern Hybridization Analysis
The cDNA fragments generated by RT-PCR were resolved on 1.2% agarose gels and transferred onto nylon membranes (Hybond-N, Amersham, Aylesbury, UK). The membranes were prehybridized for 2-4 h at 42ЊC in a total volume of 25 ml containing 5ϫ SSPE (1ϫ SSPE ϭ 180 mmol/L NaCl, 10 mmol/L sodium phosphate, and 1 mmol/ L EDTA, pH 7.7), 5ϫ Denhardt solution, 0.5% (w/v) SDS, and calf thymus DNA (20 g/L). Hybridization was performed at 42ЊC overnight in prehybridization solution after addition of the corresponding 32 P-end-labeled antisense oligo probe: 1) for PACAP mRNA: 5Ј-GGCGAGGTTCT-CGCCCATGCCCCTCGCCACCATGGA-3Ј corresponding to nucleotides 511-543 of the PACAP cDNA sequence [25] ; 2) for PACAP type I receptor R mRNA 5Ј-GATGA-GCAGTAGGGTGGAGCGGGCCAGCCG-3Ј corresponding to nucleotides 1044-1073 of the PACAP type I receptor cDNA sequence [26] . The blots were washed twice for 10 min in 2ϫ SSPE-0.1% SDS at room temperature and once in 1ϫ SSPE-0.1% SDS at 50ЊC for 30 min and then exposed to x-ray film (Kodak XAR-5, Eastman Kodak, Rochester, NY) for 2-48 h. The molecular sizes of the RT-PCR products were determined by comparison with molecular size markers run together with the DNA fragments.
Northern Hybridization Analysis
For Northern hybridization analyses, RNA samples (20 g/lane) were resolved on 1.2% denaturing agarose gel and transferred onto Hybond-N ϩ nylon membranes (Amersham) by the capillary method [30] . The membranes were prehybridized for 4 h at 64ЊC in a solution containing 50% deionized formamide (Sigma), 3ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 5ϫ Denhardt solution, 0.1 g/L heat-denatured calf thymus DNA, 1% SDS, and 0.1 g/L yeast tRNA. For hybridization, a 32 P-labeled complementary RNA (cRNA) probe for the rat PACAP was synthesized using a Riboprobe system II kit (Promega) and a fragment of PACAP cDNA (spanning nucleotides 1025-1410) subcloned into T vector pGEM-5f as template. Hybridization was performed for 18-20 h at 66ЊC in the same prehybridization solution after addition of the cRNA probe. After hybridization, the membranes were washed in 2ϫ SSC and 0.1% SDS at room temperature for 15 min, and to remove nonspecific hybridization, treated with ribonuclease-A (3 mg/L in 2ϫ SSC) for 15 min at room temperature, followed by two washes in 0.2ϫ SSC and 0.1% SDS at 64ЊC for 30 min. The filters were exposed for 18 h to imaging plates using Fujix Bio-Image Analyzer Bas 5000 (Düsseldorf, Germany).
Radioimmunoassays of Testosterone and cAMP
Testosterone was measured in the culture media by RIA as described before [31] . The assay sensitivity was 2 fmol/ tube. The intra-assay coefficient of variation (CV) was below 6% and the interassay CV below 12%. Extracellular cAMP concentrations in the culture media were assayed by RIA as described before [32] . Succinyl-cAMP, radioiodinated with Na[125I]iodide (IMS 300, Amersham) in our laboratory, served as the tracer [33] .
Pituitary Adenylate Cyclase-Activating Polypeptide Measurements
Testicular homogenates were comprised of pairs of testes from embryos at E17.5, E19.5, and E21.5. The frozen tissues were extracted by boiling in 0.9% NaCl for 10 min, followed by homogenization for 1 min and centrifugation. Each sediment was re-extracted in boiling 0.5 mol/L acetic acid for 15 min, followed by similar homogenization and centrifugation. The pooled supernatants were freeze-dried and redissolved in 1.0 ml of 0.5 mol/L sodium phosphate buffer, pH 7.5, for determination of PACAP-27 and PA-CAP-38 concentrations by RIA kits purchased from Peninsula Laboratories. The sensitivity of the PACAP assay was 10 pg/tube, and its intra-assay coefficient of variation was about 5%. All samples were analyzed in the same assay, to eliminate interassay variability.
Statistical Analysis
All values presented are means Ϯ SEM. A Macintosh version of the superANOVA program (Abacus Concepts, Inc., Berkeley, CA) was used to perform one-factor AN-OVA, followed by factorial tests and Fishers protected least significant difference posthoc tests. A P value less than 0.05 was chosen as the limit of statistical significance.
RESULTS
Stimulation of Dispersed Fetal, Neonatal, Immature, and Adult Rat Leydig Cells and MSC-1 Cells by PACAP-27 and PACAP-38
Both PACAP-38 and PACAP-27 stimulated cAMP and testosterone production by dispersed E18.5 fetal Leydig cells in culture in dose-dependent fashion (Fig. 1) . Interestingly, both PACAP-38 and PACAP-27 were effective at extremely low concentrations. Doses as low as 10 Ϫ18 mol/ L of PACAP-27 and 10 Ϫ17 -10 Ϫ16 mol/L of PACAP-38 were able to evoke significant stimulation of cAMP and testosterone production (P Ͻ 0.05). It is apparent from the cAMP dose-response curves that both forms of PACAP acted on two types of receptors, one of them at a low concentration of 10 Ϫ18 -10 Ϫ12 mol/L, and after their saturation, another type of receptor was stimulated at higher concentrations of 10 Ϫ12 -10 Ϫ7 mol/L (Fig. 1A) . Cyclic AMP production at the lower PACAP concentrations was sufficient for maximal stimulation of steroidogenesis, because no further increase of testosterone was observed at the higher levels of the secondary cAMP increase.
As a control, we assessed the dose-response of cAMP to both forms of PACAP in MSC-1 cells. We found that both peptides were effective in these cells only at doses of 10 Ϫ12 -10 Ϫ11 mol/L and higher (Fig. 2) . These results are in good agreement with a previous report [34] . Similar findings were made when we stimulated the NT-1 cells (immortalized granulosa cell line derived from a mouse ovar- ian tumor) [35] (data not shown). When we followed the effect of PACAP-27 over different ages, it continued until the age when adult-type Leydig cells replace those of the fetal population around Day 20 postpartum [36] (Fig. 3) . Accordingly, steroidogenesis of adult Leydig cells was not markedly stimulated by PACAP.
Pituitary Adenylate Cyclase-Activating Polypeptide and PACAP Receptor Gene Expression
The RT-PCR and Southern hybridization showed that PACAP and PACAP type I receptor mRNAs are expressed in the fetal rat testis as early as E15.5. Using the PACAP cDNA primers, only one amplicon of the expected size was observed (Fig. 4A) , while three bands were observed in the case of PACAP type I receptors, corresponding to the expected sizes of the known splice variants of this receptor mRNA, namely the regular PACAP receptors cDNA, the PACAP-HIP and/or PACAP-HOP receptor variants and the PACAP-HIP-HOP receptor variant [26, 37] (Fig. 4B) .
Northern hybridization analysis of total testicular RNA from pre-and postnatal rats of different ages using a PA-CAP cRNA probe showed no signal in fetal and neonatal testes. There was a faint signal in 30-day-old testes, and the level of expression increased clearly thereafter (Fig. 5) . The testicular transcript was about 0.8 kilobases (kb) in size, while it was 3.0 kb in the brain sample, in agreement with a previous report [25] .
Pituitary Adenylate Cyclase-Activating Polypeptide Measurements
Testicular PACAP-27 content was 12.9 Ϯ 0.3 ng/g on E17.5, and it decreased to 7.6 Ϯ 0.7 ng/g on E19.5, and further to 5.0 Ϯ 0.04 ng/g on E21.5. The respective concentrations of PACAP-38 were 7.0 Ϯ 0.2 ng/g on E17.5, 3.6 Ϯ 0.08 ng/g on E19.5, and 3.03 Ϯ 0.1 ng/g on E21.5 (Table 1) .
DISCUSSION
In the rat, fetal testicular steroidogenesis is activated on E15.5, whereas significant levels of pituitary LH appear in fetal circulation on E18.5 [20] . Therefore, fetal testicular steroidogenesis must start independently of LH, pointing out that some nongonadotropic autocrine, paracrine, or endocrine factor/s likely turn on and maintain this early activity. Our previous findings demonstrate that PACAP and VIP are likely candidates for such endo/paracrine stimuli of the fetal testis [20, 38] . In accordance, the results of the present study suggest that PACAP is a highly potent regulator of fetal testicular steroidogenesis, apparently engaging type I PACAP receptors.
Both PACAP forms stimulated cAMP and testosterone production of E18.5 fetal Leydig cells at concentrations as low as 10 Ϫ17 -10 Ϫ18 mol/L. Because dispersed fetal testicular cells were used in the PACAP stimulations, the possibility that part of cAMP originates from other cells than Ϫ6 mol/L PACAP-27 (r), and 30 g /L hCG (q). Each point represents the mean Ϯ SEM of three different experiments (n ϭ 6-9). The asterisks indicate significant differences from the basal (C) cAMP and testosterone production (***P Ͻ 0.001, ****P Ͻ 0.0001).
those of Leydig cannot be excluded. However, the high sensitivity of the testosterone response indicates that the Leydig cells are the site of the very sensitive response to PACAP. This peptide is at least five orders of magnitude more potent than VIP in stimulating the fetal testicular steroidogenesis [38] . As far as we know, this is the first report on a paracrine factor with such high potency. The results suggest that PACAP acts on two types of receptors to stimulate the cAMP production by fetal Leydig cells. At concentrations 10 Ϫ18 -10 Ϫ12 mol/L, it first stimulates the type I PACAP receptors that exhibit 1000-fold higher affinity for PACAP over VIP. When these receptors have become fully saturated it acts through VIP2 receptors that are expressed in the fetal testis as early as E15.5 [38] . It seems likely that the fetal testis contains a special form of PACAP type I receptors with high affinity for PACAP. Different variants of PACAP type I receptors have been proposed, as five different mRNA splice variants were identified, resulting from alternative splicing of two cassettes, named HIP and HOP [37] . These variants differ in the third intracellular loop and may have different abilities to activate adenylate cyclase or inositol triphosphate production. Radioligand binding and functional studies suggested the presence of type IA receptors that have equally high affinity for PA-CAP-27 and PACAP-38, and type IB receptors that prefer PACAP-38 over PACAP-27 [4, 8] . Some other studies suggested that the PACAP type I receptor, and its variants so far cloned correspond to type IA [8] . In most of the tissues so far studied [28, 37] , the predominant mRNA variants are the normal receptor and the HOP 1 variant. Although the RT-PCR technique used here is not quantitative, the predominant mRNA form in fetal testis had a size corresponding to the HIP and/or HOP 1 variant (with the primers used, we could not distinguish between the HIP and HOP forms), followed by the normal receptor. The large HIP-HOP form was only faintly detectable. However, further binding studies are needed to characterize the possible unique receptor subtypes of the fetal testis. In order to show the specificity of this extraordinarily potent effect of PACAP on fetal Leydig cells, we studied the dose-response relationship for both forms of PACAP in adult mouse Sertoli and granulosa tumor cell lines. We found, as did others [15, 34] , that both PACAP forms were effective in the pico-to nanomolar range but inactive at lower concentrations.
When we followed the effect of PACAP on testicular steroidogenesis through the neonatal and immature ages, the stimulatory effect disappeared between 16 and 20 days postpartum, in accordance with the time when fetal-type Leydig cells are replaced by those of the adult growth phase [36] . These results are in agreement with our previous report in which we noted that PACAP has no effect on BLT-1 cell (immortalized adult mouse Leydig cell line) cAMP and testosterone production [20] and with the results by Romanelli et al. [39] demonstrating the absence of PACAP effects on basal testosterone production by the adult Leydig cells. They are in contrast to another recent report showing a stimulatory effect of PACAP on testosterone production by adult rat Leydig cells [40] . However, the PACAP binding sites within the adult testis have been localized in the seminiferous tubules and not in the Leydig cells [4, 41] , and by immunocytochemistry PACAP immunoreactivity has been found in spermatogonia and primary spermatocytes but not in mature spermatides, spermatozoa [42] , Sertoli cells, or Leydig cells [13] . These findings support the idea that during adult life, PACAP may function as a paracrine or autocrine regulator of germ cell function, being involved in the regulation of spermatogenesis but not of steroidogenesis.
The RT-PCR data demonstrated that PACAP can be produced locally to act as a paracrine or autocrine factor within the fetal testis, although part of it can also be of extratesticular origin. Although we could demonstrate PACAP gene expression in the fetal testis as early as E15.5, its level of expression remained low during the fetal and neonatal ages. In accordance, our attempts to identify the cellular localization of expression of PACAP and its receptor by in situ hybridization were unsuccessful (results not shown). This was not unexpected, because PACAP was needed at extremely low concentrations to stimulate fetal testicular steroidogenesis. The level of PACAP gene expression increases clearly after 30 days postpartum, hinting to a role in the regulation of spermatogenesis and sexual maturation.
The endogenous fetal testicular PACAP concentrations are sufficient to stimulate fetal testicular steroidogenesis. This means that both PACAPs are available in physiologically effective concentrations in the fetal rat testes at the early ages when testicular steroidogenesis is highly active despite the absence of LH in fetal circulation [20] . In contrast to adult tissues where PACAP is mainly represented by PACAP-38 and only 10% of the total immunoreactivity formed by PACAP-27 [12] , the fetal testes contain a higher concentration of PACAP-27 than PACAP-38. However, PACAP-38 and PACAP-27 are generated from the same gene [4] , but the physiological significance of this difference and whether PACAP-27 is derived directly from PA-CAP-38 or processed independently from the precursor remains to be studied.
In conclusion, our results suggest that PACAP, possibly produced within the fetal testis, is, at extremely low concentrations, a potent stimulus of fetal testicular steroidogenesis. The magnitude of steroidogenic stimulation by PA-CAP is comparable to that evoked by hCG, and the PACAP effect is probably produced, at low concentrations, via type I PACAP receptors that are expressed in the fetal testis as early as E15.5. These results indicate that PACAP, possibly together with VIP [38] and other, as yet unidentified, nongonadotropic factors, may contribute to the early gonadotropin-independent stimulation of fetal Leydig cells.
